本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Impact Biomedical, Inc.

0.6360
-0.0086-1.33%
盤後0.63940.0034+0.53%19:36 EDT
成交量:10.93萬
成交額:6.99萬
市值:774.99萬
市盈率:-0.19
高:0.6446
開:0.6330
低:0.6330
收:0.6446
52周最高:6.17
52周最低:0.3621
股本:1,218.54萬
流通股本:1,173.81萬
量比:1.11
換手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):-3.2639
每股收益(LYR):-2.2969
淨資產收益率:-405.44%
總資產收益率:-8.24%
市淨率:-0.75
市盈率(LYR):-0.28

資料載入中...

2024/09/03

SEC問詢函

Form CORRESP - Correspondence
2024/09/03

SEC問詢函

Form CORRESP - Correspondence
2024/08/27

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/20

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

SEC問詢函

Form CORRESP - Correspondence
2024/08/12

SEC問詢函

Form CORRESP - Correspondence
2024/08/09

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/08

SEC問詢函

Form CORRESP - Correspondence
2024/08/08

SEC問詢函

Form CORRESP - Correspondence
2024/06/11

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/02/28

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/20

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/01/22

重要事件披露

Form 8-K - Current report
2023/11/21

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/01

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]